Hycodan Oral Tablet 5-1.5Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Hycodan: Oral tablet (5-1.5mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_3386.JPG
Hycodan 1.5mg-5mg Tab
Endo Pharmaceuticals Inc
Pill Identification: HYCODAN 
Drug Image file DrugItem_5528.JPG
Hydrocod/Homatrop 5-1.5mg Tab
Actavis Inc. formerly Amide Pharmaceutical Inc
Pill Identification: A 140 
Drug Image file DrugItem_9109.JPG
Hydrocod/Homatrop 5-1.5mg Tab
Actavis Inc. Towata LLC
Pill Identification: A 140 
Drug Image file DrugItem_10029.JPG
Tussigon 1.5mg-5mg Tab
Monarch Pharmaceuticals Inc a Pfizer Company
Pill Identification: TUSSIGON  |  dp 082
Drug Image file DrugItem_14358.JPG
Hydrocod/Homatrop 5-1.5mg Tab
Gavis Pharmaceuticals, LLC
Pill Identification: N 350 
Drug Image file DrugItem_18813.JPG
Hydrocod/Homatrop 5-1.5mg Tab
Gavis Pharmaceuticals, LLC
Pill Identification: N 350 

What is this Medicine?

HYDROCODONE (hye droe KOE done) is used to help relieve cough.

In-Depth Information

Hycodan 1.5mg-5mg Tablet

NDC: 634810042
  • Prescription Required
  • Federally Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Cough

Storage Information
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Hycodan 1.5mg-5mg Tablet
Drug Image file DrugItem_3386.JPG
Endo Pharmaceuticals Inc
Pill Identification: HYCODAN 
Shape: round
Color: white

Reported Side Effects for Hycodan 1.5mg-5mg Tablet

Elated Mood Incidence:
>10.0%*
Severity: MODERATE
Onset: EARLY
Lightheadedness Incidence:
>10.0%*
Severity: MILD
Onset: EARLY
Miosis Incidence:
>10.0%*
Severity: MILD
Onset: EARLY
Addiction Incidence:
>10.0%*
Severity: MODERATE
Onset: DELAYED
Addiction Incidence:
>10.0%*
Severity: MODERATE
Onset: DELAYED
Drowsiness Incidence:
>10.0%*
Severity: MILD
Onset: EARLY
Constipation Incidence:
>10.0%*
Severity: MODERATE
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Hycodan 1.5mg-5mg Tablet

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Major Lifestyle Interaction
Alcohol and Hycodan 1.5mg-5mg Tablet(Hydrocodone Bitartrate)
Alcohol and CNS Depressants(Hydrocodone Bitartrate)
Avoid alcohol-containing drinks while taking this medicine. Using this drug along with alcohol can lead to serious side effects. You may feel drowsy or more tired when taking these drugs together. Do not drive or operate machinery until you know how this drug affects you, and especially if you are drinking alcohol-containing beverages. If you notice slurred speech, confusion, severe weakness, or difficulty breathing, contact your health care provider immediately.
Major Lifestyle Interaction
Grapefruit juice and Hycodan 1.5mg-5mg Tablet(Hydrocodone Bitartrate)
Grapefruit juice and Hydrocodone(Hydrocodone Bitartrate)
Side effects from Hydrocodone may get worse if you eat or drink grapefruit juice. Talk to your doctor first. Contact your doctor right away if you have slurred speech, confusion, weakness, or trouble breathing. Do not drive or operate machinery until you know how this affects you.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More